CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in FULC — Fulcrum Therapeutics, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in FULC
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,274,085
-$1,124,328 QoQ
Shares Held
426,869
+9.8% QoQ
Ownership
0.641%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#31
of 168 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in FULC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $6,184,692,793 across 287 Biotechnology names. FULC ranks #152 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,920,871 | $857,745,736 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
804,508 | $621,595,061 | |
| 3 | MRNA |
Moderna, Inc.
|
4,734,356 | $240,505,284 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
673,356 | $222,793,299 | |
| 5 | INSM |
INSMED Inc
|
1,069,390 | $174,866,652 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
1,735,476 | $168,775,041 | |
| 7 | INCY |
Incyte Corp
|
1,729,102 | $162,743,080 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,976,094 | $146,744,740 |
All Filings in FULC
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,274,085 | 426,869 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $4,398,413 | 388,896 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,068,043 | 333,483 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $2,667,940 | 387,782 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,098,313 | 381,359 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $2,472,411 | 526,045 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $2,031,990 | 569,185 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,091,094 | 175,983 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $231,138 | 24,485 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $165,273 | 24,485 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $108,713 | 24,485 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $80,800 | 24,485 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $402,736 | 141,311 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $836,377 | 114,887 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $750,517 | 92,771 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $421,003 | 85,919 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,707,742 | 72,209 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,246,879 | 70,485 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $1,899,887 | 67,348 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $568,896 | 54,284 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $513,961 | 43,630 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $433,433 | 37,014 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $259,374 | 32,708 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $545,005 | 29,798 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $319,621 | 26,769 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||